Skip to main content
Journal cover image

The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion

Publication ,  Conference
Hjelmeland, AB; Lattimore, K; Fee, B; Wickman, S; Keir, ST; Hjelmeland, MD; Batt, D; Lane, H; Bigner, DD; Friedman, HS; Rich, JN
Published in: NEURO-ONCOLOGY
October 1, 2006

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

412 / 412

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hjelmeland, A. B., Lattimore, K., Fee, B., Wickman, S., Keir, S. T., Hjelmeland, M. D., … Rich, J. N. (2006). The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion. In NEURO-ONCOLOGY (Vol. 8, pp. 412–412). Vienna, AUSTRIA: DUKE UNIV PRESS.
Hjelmeland, Anita B., Katie Lattimore, Brian Fee, Sarah Wickman, Stephen T. Keir, Mark D. Hjelmeland, David Batt, et al. “The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion.” In NEURO-ONCOLOGY, 8:412–412. DUKE UNIV PRESS, 2006.
Hjelmeland AB, Lattimore K, Fee B, Wickman S, Keir ST, Hjelmeland MD, et al. The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 412–412.
Hjelmeland, Anita B., et al. “The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion.” NEURO-ONCOLOGY, vol. 8, no. 4, DUKE UNIV PRESS, 2006, pp. 412–412.
Hjelmeland AB, Lattimore K, Fee B, Wickman S, Keir ST, Hjelmeland MD, Batt D, Lane H, Bigner DD, Friedman HS, Rich JN. The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 412–412.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

412 / 412

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences